Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Solesence (SLSN) EBT (2016 - 2025)

Historic EBT for Solesence (SLSN) over the last 16 years, with Q3 2025 value amounting to -$1.1 million.

  • Solesence's EBT fell 13678.16% to -$1.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.7 million, marking a year-over-year decrease of 3690.12%. This contributed to the annual value of $4.5 million for FY2024, which is 20177.92% up from last year.
  • As of Q3 2025, Solesence's EBT stood at -$1.1 million, which was down 13678.16% from $3.1 million recorded in Q2 2025.
  • In the past 5 years, Solesence's EBT registered a high of $3.1 million during Q2 2025, and its lowest value of -$2.1 million during Q4 2023.
  • Over the past 5 years, Solesence's median EBT value was $50000.0 (recorded in 2022), while the average stood at $95421.1.
  • As far as peak fluctuations go, Solesence's EBT surged by 88443.11% in 2021, and later plummeted by 196935.48% in 2023.
  • Quarter analysis of 5 years shows Solesence's EBT stood at -$357000.0 in 2021, then crashed by 460.78% to -$2.0 million in 2022, then dropped by 5.99% to -$2.1 million in 2023, then skyrocketed by 84.4% to -$331000.0 in 2024, then crashed by 238.37% to -$1.1 million in 2025.
  • Its EBT stands at -$1.1 million for Q3 2025, versus $3.1 million for Q2 2025 and $80000.0 for Q1 2025.